Date: Tuesday 17 Dec 2013
LONDON (ShareCast) - Advanced Medical Solutions: Panmure Gordon downgrades from buy to hold with a target price of 102p.
Antofagasta: Canaccord Genuity cuts target price from 1110p to 1035p, while staying with its buy recommendation.
ASOS: Panmure Gordon increases target price from 5950p to 6126p, while downgrading from buy to hold.
AstraZeneca: Deutsche Bank raises target price from 3425p to 3600p maintaining a hold recommendation.
blur Group: Panmure Gordon ups target price from 677p to 690p and retains a buy recommendation.
British American Tabacco: UBS reduces target price from 3850p to 3715p, while its buy recommendation remains unchanged.
BTG: Deutsche Bank ups target price from 565p to 610p and reiterates its buy recommendation.
Cable & Wireless Communications: Barclays shifts target price from 40p to 43p and retains an equal-weight rating.
Daily Mail & General Trust: Westhouse Securities raises target price from 744p to 864p and maintains a neutral rating.
Daisy Group: Barclays moves target price from 115p to 130p, but downgrades to underweight.
Dixons Retail: Cantor Fitzgerald ups target price from 50p to 60p keeping a buy recommendation. Investec shifts target price from 60p to 62p retaining its buy recommendation.
Europa Oil & Gas: Northland lowers target price from 14.3p to 10.1p leaving its buy recommendation unchanged.
Experian: Jefferies reduces target price from 1200p to 1090p and keeps a hold recommendation.
First Derivates: Panmure Gordon raises target price from 1191p to 1458p and keeps a buy recommendation.
First Group: Goldman Sachs shifts target price from 135p to 140p and retains a buy recommendation.
GlaxoSmithKline: Deutsche Bank reduces target price from 1800p to 1700p while downgrading to hold.
Go-Ahead Group: Goldman Sachs increases target price from 1580p to 2100p and upgrades to a strong buy recommendation.
Imagination Technologies: Barclays cuts target price from 250p to 185p and reiterates an equal-weight rating.
Informa: Canaccord Genuity cuts target price from 600p to 568p downgrading from buy to hold.
Inmarsat: Barclays takes target price from 705p to 740p and keeps an equal-weight rating.
KCOM Group: Barclays moves target price from 100p to 115p retaining its overweight rating.
Sepura: Westhouse Securities upgrades from add to buy with an unchanged target price of 160p.
Stagecoach Group: Goldman Sachs downgrades to sell with a target price of 350p.
Trinity Mirror: Panmure Gordon increases target price from 205p to 300p maintaining a buy recommendation.
UBM: Deutsche Bank moves target price from 830p to 840p retaining a buy recommendation. Westhouse Securities reduces target price from 812p to 755p, while staying with its buy recommendation. Numis cuts target price from 732p to 710p and maintains a hold recommendation. Barclays reduces target price from 810p to 755p, while staying with its overweight rating.
William Hill: Canaccord Genuity lowers target price from 425p to 408p leaving its hold recommendation unaltered.
Wood Group: Canaccord Genuity cuts target price from 875p to 825p and reiterates a hold recommendation.
Xcite Energy: Cantor Fitzgerald shapes target price from 168p to 167p leaving its buy recommendation unchanged.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 210.50p |
Change Today | -6.00p |
% Change | -2.77 % |
52 Week High | 258.00 |
52 Week Low | 177.20 |
Volume | 1,110,630 |
Shares Issued | 217.41m |
Market Cap | £457.65m |
RiskGrade | 156 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 2 |
Sell | 1 |
Strong Sell | 0 |
Total | 9 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 30-May-24 | 28-Sep-23 |
Paid | 21-Jun-24 | 27-Oct-23 |
Amount | 1.66p | 0.70p |
Time | Volume / Share Price |
16:39 | 51,000 @ 213.89p |
16:39 | 51,000 @ 214.00p |
16:38 | 50,000 @ 210.15p |
16:36 | 75,000 @ 216.38p |
16:35 | 65,766 @ 210.50p |
CEO | A Christopher (Chris) Meredith |
CFO | Eddie Johnson |
Chair | Liz Shanahan |
You are here: research